phlebotomy training in california phlebotomy training in alabama phlebotomy certification nc
Sunday, 6 October 2013
Novartis says drug reduces itch of severe chronic hives
ZURICH (Reuters) - Swiss drugmaker Novartis said on Saturday its drug omalizumab was almost doubly effective in improving quality of life for patients with a severe form of hives, compared with a placebo, according to a late-stage study. (Source: Reuters: Health)
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment